THERALASE Trademark

Trademark Overview


On Friday, April 1, 2022, a trademark application was filed for THERALASE with the United States Patent and Trademark Office. The USPTO has given the THERALASE trademark a serial number of 97343587. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, April 17, 2024. This trademark is owned by Theralase Technologies Inc.. The THERALASE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; tumor suppressing agents; photosensitizing agents for photodynamic therapy, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill pathogens; disinfectant compositions activatable by light and/or ionizing radiation to kill pathogens; photosensitizing compositions in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells
theralase

General Information


Serial Number97343587
Word MarkTHERALASE
Filing DateFriday, April 1, 2022
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, April 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-cancer preparations; tumor suppressing agents; photosensitizing agents for photodynamic therapy, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill pathogens; disinfectant compositions activatable by light and/or ionizing radiation to kill pathogens; photosensitizing compositions in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTheralase Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M4B3G4
CA

Trademark Events


Event DateEvent Description
Tuesday, April 5, 2022NEW APPLICATION ENTERED
Wednesday, April 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 18, 2023ASSIGNED TO EXAMINER
Tuesday, January 24, 2023SUSPENSION LETTER WRITTEN
Tuesday, January 24, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, January 24, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 8, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 29, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, August 29, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 29, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 28, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 17, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 17, 2024SUSPENSION LETTER WRITTEN
Wednesday, April 17, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, April 17, 2024ASSIGNED TO LIE
Wednesday, April 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 24, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION